A Single-use Strategy to Enable Manufacturing of Affordable Biologics

The current processing paradigm of large manufacturing facilities dedicated to single product production is no longer an effective approach for best manufacturing practices. Increasing competition for new indications and the launch of biosimilars for the monoclonal antibody market have put pressure...

Descripción completa

Detalles Bibliográficos
Autores principales: Jacquemart, Renaud, Vandersluis, Melissa, Zhao, Mochao, Sukhija, Karan, Sidhu, Navneet, Stout, Jim
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Research Network of Computational and Structural Biotechnology 2016
Materias:
Short Survey
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4990569/
https://www.ncbi.nlm.nih.gov/pubmed/27570613
http://dx.doi.org/10.1016/j.csbj.2016.06.007

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4990569/
https://www.ncbi.nlm.nih.gov/pubmed/27570613
http://dx.doi.org/10.1016/j.csbj.2016.06.007

Ejemplares similares